Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semuloparin for VTE prevention in cancer patients undergoing chemotherapy
NCT00694382Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Primary completion
- Nov 2010
- Modality
- Peptides, Small Molecules
- Countries
- 49
01
Overview
A Phase 3 trial of semuloparin in venous thromboembolism (VTE), sponsored by Sanofi. Started Jun 2008; status: completed.
02
Drugs
semuloparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00694382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694382.